Valence ロゴ
人気
ログイン
Loading data for CATX — first visit, this takes a few seconds.

ウォッチリストに追加

Perspective Therapeutics ...

NYSE American: CATX · リアルタイム株価 · USD
3.30
+0.09 (2.80%)
終値時点： Aug 21, 2026, 8:00 PM
3.39
+2.73%
寄り付き前: 7:57 AM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Perspective Therapeutics Inc.（CATX）の株価・分析・データ

2.80%

データがありません

買気配3.16
時価総額376.7M
売上高（TTM）409K
純利益（TTM）-116.63M
1.80
-1.33
n/a
-3.24
PBR（TTM）1.16
PSR（TTM）921.03
決算発表日Nov 9, 2026
売気配3.48
出来高1,135,263
平均出来高（20日）1,692,706
始値3.25
前日終値3.21
当日レンジ3.22 - 3.43
52週レンジ1.96 - 6.16
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

CATXについて

Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted r...

[続きを読む]
業種 Medical Devices
セクター Healthcare
IPO日 Nov 10, 2005
従業員数 163
上場取引所 NYSE American
ティッカー CATX
ウェブサイト https://www.perspectivetherapeutics.com
企業情報の全文

業績

2025年のPerspective Therapeuticsの売上高は0で、前年の0からundefined%の増加でした。 利益は-103.12Mで、30.07%の増加でした。

財務諸表

決算サプライズ

Perspective TherapeuticsはAug 10, 2026に四半期決算を発表しました：
  • 売上高は $0 で、予想を下回りました $0, うち NaN% の前年比増加にあたります.
  • EPSは -0.22 で、予想を上回りました 0.05, うち 26.67% の前年比増加にあたります.

次回決算発表

Perspective Therapeutics Inc.の決算発表予定日は Nov 9, 2026, 取引時間中の予定です。
アナリストの売上高予想は ... アップグレード
news image

1週間前 · MT Newswires

Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says

Perspective Therapeutics' (CATX) NET program to potentially treat neuroendocrine tumors may be advan

news image

2週間前 · Zacks

Profound Medical (PROF) Q2 Earnings Surpass Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of +218.18% and -55.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

news image

2週間前 · Zacks

Are Medical Stocks Lagging Perspective Therapeutics, Inc. (CATX) This Year?

Here is how Perspective Therapeutics (CATX) and Bristol Myers Squibb (BMY) have performed compared to their sector so far this year.

news image

3週間前 · Zacks

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Medical sector earnings are off to a strong start, and four biotech companies are positioned to potentially beat estimates in upcoming quarterly results.

news image

3週間前 · Zacks

Perspective Therapeutics (CATX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Perspective Therapeutics (CATX), indicating that the stock has found support. This, combined with an upward trend in earnings...

2ページ中1ページ